Cargando…
An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinoma
BACKGROUND: Aberrant glycosylation has been recognized as a hallmark of cancer and N-glycosylation is one of the main types of glycosylation in eukaryotes. Although N-glycoproteomics has made contributions to the discovery of biomarkers in a variety of cancers, less is known about the abnormal glyco...
Autores principales: | Gao, Yingzhen, Shen, Liuyi, Dong, Tianyue, Yang, Xin, Cui, Heyang, Guo, Yanlin, Ma, Yanchun, Kong, Pengzhou, Cheng, Xiaolong, Zhang, Ling, Cui, Yongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233802/ https://www.ncbi.nlm.nih.gov/pubmed/35752862 http://dx.doi.org/10.1186/s12967-022-03489-2 |
Ejemplares similares
-
TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2
por: Zhang, Ling, et al.
Publicado: (2020) -
Elevated DHODH expression promotes cell proliferation via stabilizing β-catenin in esophageal squamous cell carcinoma
por: Qian, Yu, et al.
Publicado: (2020) -
FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma
por: Hu, Xiaoling, et al.
Publicado: (2018) -
Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma
por: Zou, Binbin, et al.
Publicado: (2022) -
CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
por: Li, Hongyi, et al.
Publicado: (2021)